Mirna makes Casi DeYoung CBO
This article was originally published in Scrip
Executive Summary
Mirna Therapeutics, a private, clinical-stage biopharmaceutical company focused on the development of microRNA-based oncology therapeutics, has appointed Casi DeYoung chief business officer. Ms DeYoung most recently served as vice-president of business development at Reata Pharmaceuticals from 2008.